1,437
Views
95
CrossRef citations to date
0
Altmetric
Research Article

Surgical procedures in the treatment of 784 infected THAs reported to the Norwegian Arthroplasty Register

Best survival with 2-stage exchange revision, but also good results with debridement and retention of the fixed implant

, , , &
Pages 530-537 | Received 21 Jan 2011, Accepted 30 May 2011, Published online: 24 Nov 2011

  • Azzam KA, Seeley M, Ghanem E, Austin MS, Purtill JJ, Parvizi J. Irrigation and debridement in the management of prosthetic joint infection: traditional indications revisited. J Arthroplasty 2010; 25 (7): 1022-7.
  • Bejon P, Berendt A, Atkins BL, Green N, Parry H, Masters S, Lardy-Smith P, Gundle R, Byren I. Two-stage revision for prosthetic joint infection: predictors of outcome and the role of reimplantation microbiology. J Antimicrob Chemother 2010; 65 (3): 569-75.
  • Biring GS, Kostamo T, Garbuz DS, Masri BA, Duncan CP. Two-stage revision arthroplasty of the hip for infection using an interim articulated Prostalac hip spacer: a 10- to 15-year follow-up study. J Bone Joint Surg (Br) 2009; 91 (11): 1431-7.
  • Bozic KJ, Kurtz SM, Lau E, Ong K, Vail TP, Berry DJ. The epidemiology of revision total hip arthroplasty in the United States. J Bone Joint Surg (Am) 2009; 91 (1): 128-33.
  • Byren I, Bejon P, Atkins BL, Angus B, Masters S, Lardy-Smith P, Gundle R, Berendt A. One hundred and twelve infected arthroplasties treated with ‘DAIR’ (debridement, antibiotics and implant retention): antibiotic duration and outcome. J Antimicrob Chemother 2009; 63 (6): 1264-71.
  • Dale H, Hallan G, Espehaug B, Havelin LI, Engesaeter LB. Increasing risk of revision due to deep infection after hip arthroplasty. Acta Orthop 2009; 80 (6): 639-45.
  • Fink B. Revision of late periprosthetic infections of total hip endoprostheses: pros and cons of different concepts. Int J Med Sci 2009; 6 (5): 287-95.
  • Giulieri SG, Graber P, Ochsner PE, Zimmerli W. Management of infection associated with total hip arthroplasty according to a treatment algorithm. Infection 2004; 32 (4): 222-8.
  • Havelin LI, Engesaeter LB, Espehaug B, Furnes O, Lie SA, Vollset SE. The Norwegian Arthroplasty Register: 11 years and 73,000 arthroplasties. Acta Orthop Scand 2000; 71 (4): 337-53.
  • Jafari SM, Coyle C, Mortazavi SM, Sharkey PF, Parvizi J. Revision hip arthroplasty: infection is the most common cause of failure. Clin Orthop 2010; (468) (8): 2046-51.
  • Kurtz SM, Lau E, Schmier J, Ong KL, Zhao K, Parvizi J. Infection burden for hip and knee arthroplasty in the United States. J Arthroplasty 2008; 23 (7): 984-91.
  • Langlais F. Can we improve the results of revision arthroplasty for infected total hip replacement? J Bone Joint Surg (Br) 2003; 85(5): 637-40.
  • Lidgren L. Joint prosthetic infections: a success story. Acta Orthop Scand 2001; 72 (6): 553-6.
  • Lidgren L, Knutson K, Stefansdottir A. Infection and arthritis. Infection of prosthetic joints. Best Pract Res Clin Rheumatol 2003; 17 (2): 209-18.
  • Marculescu CE, Berbari EF, Hanssen AD, Steckelberg JM, Harmsen SW, Mandrekar JN, Osmon DR. Outcome of prosthetic joint infections treated with debridement and retention of components. Clin Infect Dis 2006; 42 (4): 471-8.
  • Moojen DJ, van HG, Vogely HC, Burger BJ, Walenkamp GH, Tulp NJ, Schreurs BW, de Meulemeester FR, Schot CS, van dP,I, Fujishiro T, Schouls LM, Bauer TW, Dhert WJ. Incidence of low-grade infection in aseptic loosening of total hip arthroplasty. Acta Orthop 2010; 81 (6): 667-73.
  • Norwegian Arthrorplasty Register, Annual Report 2009. http://nrlweb.ihelse.net/Rapporter/Rapport2009.pdf
  • Ong KL, Kurtz SM, Lau E, Bozic KJ, Berry DJ, Parvizi J. Prosthetic joint infection risk after total hip arthroplasty in the Medicare population. J Arthroplasty (6 Suppl) 2009; 24: 105-9.
  • Pedersen AB, Svendsson JE, Johnsen SP, Riis A, Overgaard S. Risk factors for revision due to infection after primary total hip arthroplasty. A population-based study of 80,756 primary procedures in the Danish Hip Arthroplasty Registry. Acta Orthop 2010; 81 (5): 542-7.
  • Stockley I, Mockford BJ, Hoad-Reddick A, Norman P. The use of two-stage exchange arthroplasty with depot antibiotics in the absence of long-term antibiotic therapy in infected total hip replacement. J Bone Joint Surg (Br) 2008; 90 (2): 145-8.
  • Toms AD, Davidson D, Masri BA, Duncan CP. The management of peri-prosthetic infection in total joint arthroplasty. J Bone Joint Surg (Br) 2006; 88 (2): 149-55.
  • Trampuz A, Zimmerli W. Diagnosis and treatment of infections associated with fracture-fixation devices. Injury (Suppl 2) 2006; 37: S59-S66.
  • Trebse R, Pisot V, Trampuz A. Treatment of infected retained implants. J Bone Joint Surg (Br) 2005; 87 (2): 249-56.
  • Urquhart DM, Hanna FS, Brennan SL, Wluka AE, Leder K, Cameron PA, Graves SE, Cicuttini FM. Incidence and risk factors for deep surgical site infection after primary total hip arthroplasty: a systematic review. J Arthroplasty 2010; 25 (8): 1216-22.
  • Walenkamp GH. Joint prosthetic infections: a success story or a continuous concern? Acta Orthop 2009; 80 (6): 629-32.
  • Winkler H. Rationale for one stage exchange of infected hip replacement using uncemented implants and antibiotic impregnated bone graft. Int J Med Sci 2009; 6 (5): 247-52.
  • Zimmerli W, Ochsner PE. Management of infection associated with prosthetic joints. Infection 2003; 31 (2): 99-108.
  • Zimmerli W, Trampuz A, Ochsner PE. Prosthetic-joint infections. N Engl J Med 2004; 351 (16): 1645-54.